HAMILTON, ON, May 26, 2021 / – Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has resumed onboarding with Rural Health Clinics and Federally Qualified Health Centers thanks to the significantly reduced COVID numbers in the US.

“Remote Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) were on the front lines during the pandemic, providing COVID testing, treatment, and more recently serving as COVID vaccination sites for local communities”, said Dr. Lisa Crossley, CEO of Reliq Health Technologies. “There are over 4,500 RHCs and FQHCs across the US. Remote Health Clinics provide primary care services to Medicare patients in rural and underserved or “shortage” areas. Federally Qualified Health Centers provide both primary care and dental care services to rural, urban and shortage areas. After pausing onboarding at our RHC and FQHC client sites at the start of the pandemic in March 2020, we are now pleased to announce that onboarding has resumed with these clients. We expect to onboard over 27,000 RHC and FQHC patients over the next 12 months. These healthcare organizations will be using Reliq’s Remote Patient Monitoring (RPM), Chronic Care Management (CCM), Behavioral Health Integration (BHI) and Transitional Care Management services to help improve patient health outcomes and enhance access to care. We expect to generate an average revenue of $50 USD per patient per month with these clinics.”

Reliq Health

Reliq Health Technologies is a rapidly growing global telemedicine company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery.  iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.  Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB. 


“Dr. Lisa Crossley”

CEO and Director

For further information please contact:

Company Contact

Investor Relations at ir@reliqhealth.com

US Investor Relations Contact

Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”. 

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. 

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.  

Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements. 

SOURCE: Reliq Health Technologies Inc.